Tinea corporis/cruris: New treatment options

Dermatology

Volumn 194, Issue 1, 1997, Pages 14-18

  Van Heerden, J S ^a   Vismer, H F ^b  

^a Private Practice   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Clinical trial; Gel; Mycological cure; Placebo; Topical treatment

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TINEA CORPORIS; TINEA CRURIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TINEA; TREATMENT OUTCOME;

EID: 0031002703     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246177     Document Type: Article

References (5)

1. Pctranyi G, Meingassner JG, Meith H: Antifungal activity of the allylamine derivative terbinafine in vitro., Antimicrob Agents Chemother 1987;31:1365-1368.
2. Clayton YM: In vitro activity of terbinafine., Clin Exp Dermatol 1989; 14:101-104.
3. Berman B, Ellis C, Leydon J., Lowe N., Savin R., Shupak J, et al: Efficacy of a I-week, twice daily regimen of terbinafine \% cream in the treatment of interdigital tinea pedis., J Am Acad Dermatol 1992;26:956-960.
4. Millikan LE: Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris., J Am Acad Dermatol 1990;23:795-799.
5. Evans EGV, Shah JM, Joshipura RC: One-week treatment of tinea coiporis and tinea cruris with terbinafine (Lamisil®) 1% cream: A placebo-controlled study., J Dermatol Treat 1992:3:181-184.